HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Red blood cells are essential for carrying oxygen throughout the body. In some cases, people do not have enough red blood cells to deliver the amount of oxygen needed for healthy functioning. This condition, known as anemia, can occur for a variety of reasons and can take many forms. , Regional Cancer Care Associates has the expertise and resources to treat or control anemia and other conditions, and provides patients with expert care at convenient locations in New Jersey, Connecticut, Maryland, and the Washington, D.C. area.
We’re here for you. Call us at 844-346-7222 or
Because red blood cells are responsible for transporting oxygen from the lungs to the rest of the body, they are vital to ensuring that the body has enough energy for the day. Red blood cells contain a protein called hemoglobin, which aids in carrying oxygen and carbon dioxide throughout the body. Anemia, or low hemoglobin levels, occurs when the body fails to produce enough red blood cells or prematurely destroys red blood cells.
As noted, anemia can arise for many reasons. Some people develop the condition at birth, but it also can arise at any age. Anemia occurs when the body cannot produce an adequate amount of red blood cells, loses red blood cells faster than it can replace them, or eliminates red blood cells. Risk factors for anemia include:
Symptoms can range from mild to severe depending on the cause of a patient’s anemia and other factors. In some instances, people with anemia may not feel symptoms at all. However, symptoms can appear or grow more severe if anemia worsens. Symptoms of anemia include:
There are many forms of anemia. Based on a thorough history and examination, along with blood work, physicians may diagnose a person with:
To diagnose which anemic condition a patient may have, physicians may conduct a variety of tests such as:
The hematology specialists and other health care professionals at Regional Cancer Care Associates use state-of-the-art technology and l practices to treat and control anemia. Depending on the severity and type of anemia, our physicians may suggest making lifestyle changes or taking supplements and medications to relieve symptoms. For severe cases, patients may undergo a blood transfusion, bone marrow transplant, or other treatment.
With a dedication to creating a comfortable health care environment, Regional Cancer Care Associates utilizes personalized care for patients in New Jersey, Connecticut, Maryland, and the Washington, D.C. area. To learn more about our anemia treatment services, request an appointment today.
RCCA offers cutting-edge treatment options for every type of cancer. Our expert care teams can match you with the treatment plan that fits your needs. LEARN MORE
Improve your quality of life and learn to manage life with cancer through our integrative services. We offer several solutions to support and promote physical, mental, emotional, and spiritual health. LEARN MORE
The field of cancer treatment is constantly improving and evolving. RCCA conducts hundreds of clinical trials that can help develop new therapies and treatment plans. LEARN MORE
If you need near-term or ongoing care for anemia or another benign blood disorder, schedule an appointment at Regional Cancer Care Associates. Patients have access to a full range of services across New Jersey, Connecticut, Maryland, and the Washington, DC area, making it easy to find a location convenient for you. Contact us today to learn more about our benign hematology services.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.